132 related articles for article (PubMed ID: 11468164)
1. The impaired polymerization of fibrinogen Longmont (Bbeta166Arg-->Cys) is not improved by removal of disulfide-linked dimers from a mixture of dimers and cysteine-linked monomers.
Lounes KC; Lefkowitz JB; Henschen-Edman AH; Coates AI; Hantgan RR; Lord ST
Blood; 2001 Aug; 98(3):661-6. PubMed ID: 11468164
[TBL] [Abstract][Full Text] [Related]
2. Fibrinogen Longmont. A heterozygous abnormal fibrinogen with B beta Arg-166 to Cys substitution associated with defective fibrin polymerization.
Lounes KC; Lefkowitz JB; Coates AI; Hantgan RR; Henschen-Edman A; Lord ST
Ann N Y Acad Sci; 2001; 936():129-32. PubMed ID: 11460470
[TBL] [Abstract][Full Text] [Related]
3. A new substitution, gamma 358 Ser-->Cys, in fibrinogen Milano VII causes defective fibrin polymerization.
Steinmann C; Bögli C; Jungo M; Lämmle B; Heinemann G; Wermuth B; Redaelli R; Baudo F; Furlan M
Blood; 1994 Sep; 84(6):1874-80. PubMed ID: 8080993
[TBL] [Abstract][Full Text] [Related]
4. Functional analysis of recombinant Bbeta15C and Bbeta15A fibrinogens demonstrates that Bbeta15G residue plays important roles in FPB release and in lateral aggregation of protofibrils.
Hirota-Kawadobora M; Kani S; Terasawa F; Fujihara N; Yamauchi K; Tozuka M; Okumura N
J Thromb Haemost; 2005 May; 3(5):983-90. PubMed ID: 15869595
[TBL] [Abstract][Full Text] [Related]
5. Fibrinopeptide A release is necessary for effective B:b interactions in polymerisation of variant fibrinogens with impaired A:a interactions.
Soya K; Terasawa F; Okumura N
Thromb Haemost; 2013 Feb; 109(2):221-8. PubMed ID: 23238100
[TBL] [Abstract][Full Text] [Related]
6. Fibrinogen Ledyard (A alpha Arg16----Cys): biochemical and physiologic characterization.
Lee MH; Kaczmarek E; Chin DT; Oda A; McIntosh S; Bauer KA; Clyne LP; McDonagh J
Blood; 1991 Oct; 78(7):1744-52. PubMed ID: 1912564
[TBL] [Abstract][Full Text] [Related]
7. Abnormal fibrinogens IJmuiden (B beta Arg14----Cys) and Nijmegen (B beta Arg44----Cys) form disulfide-linked fibrinogen-albumin complexes.
Koopman J; Haverkate F; Grimbergen J; Engesser L; Nováková I; Kerst AF; Lord ST
Proc Natl Acad Sci U S A; 1992 Apr; 89(8):3478-82. PubMed ID: 1565641
[TBL] [Abstract][Full Text] [Related]
8. Fibrinogen Matsumoto III: a variant with gamma275 Arg-->Cys (CGC-->TGC)--comparison of fibrin polymerization properties with those of Matsumoto I (gamma364 Asp-->His) and Matsumoto II (gamma308 Asn-->Lys).
Terasawa F; Okumura N; Higuchi Y; Ishikawa S; Tozuka M; Ishida F; Kitano K; Katsuyama T
Thromb Haemost; 1999 May; 81(5):763-6. PubMed ID: 10365751
[TBL] [Abstract][Full Text] [Related]
9. Fibrinogen Alès: a homozygous case of dysfibrinogenemia (gamma-Asp(330)-->Val) characterized by a defective fibrin polymerization site "a".
Lounes KC; Soria C; Mirshahi SS; Desvignes P; Mirshahi M; Bertrand O; Bonnet P; Koopman J; Soria J
Blood; 2000 Nov; 96(10):3473-9. PubMed ID: 11071644
[TBL] [Abstract][Full Text] [Related]
10. Recombinant fibrinogen, gamma275Arg-->Cys, exhibits formation of disulfide bond with cysteine and severely impaired D:D interactions.
Ishikawa S; Hirota-Kawadobora M; Tozuka M; Ishii K; Terasawa F; Okumura N
J Thromb Haemost; 2004 Mar; 2(3):468-75. PubMed ID: 15009465
[TBL] [Abstract][Full Text] [Related]
11. Substitution of gamma Arg-275 by Cys in an abnormal fibrinogen, "fibrinogen Osaka II". Evidence for a unique solitary cystine structure at the mutation site.
Terukina S; Matsuda M; Hirata H; Takeda Y; Miyata T; Takao T; Shimonishi Y
J Biol Chem; 1988 Sep; 263(27):13579-87. PubMed ID: 2971042
[TBL] [Abstract][Full Text] [Related]
12. End-linked homodimers in fibrinogen Osaka VI with a B beta-chain extension lead to fragile clot structure.
Sugo T; Nakamikawa C; Yoshida N; Niwa K; Sameshima M; Mimuro J; Weisel JW; Nagita A; Matsuda M
Blood; 2000 Dec; 96(12):3779-85. PubMed ID: 11090060
[TBL] [Abstract][Full Text] [Related]
13. An abnormal fibrinogen Fukuoka II (Gly-B beta 15-->Cys) characterized by defective fibrin lateral association and mixed disulfide formation.
Kamura T; Tsuda H; Yae Y; Hattori S; Ohga S; Shibata Y; Kawabata S; Hamasaki N
J Biol Chem; 1995 Dec; 270(49):29392-9. PubMed ID: 7493975
[TBL] [Abstract][Full Text] [Related]
14. Fibrinogen St. Gallen I (gamma 292 Gly--> Val): evidence for structural alterations causing defective polymerization and fibrinogenolysis.
Stucki B; Schmutz P; Schmid L; Haeberli A; Lämmle B; Furlan M
Thromb Haemost; 1999 Feb; 81(2):268-74. PubMed ID: 10064005
[TBL] [Abstract][Full Text] [Related]
15. Analysis of fibrinogen variants at gamma387Ile shows that the side chain of gamma387 and the tertiary structure of the gammaC-terminal tail are important not only for assembly and secretion of fibrinogen but also for lateral aggregation of protofibrils and XIIIa-catalyzed gamma-gamma dimer formation.
Kani S; Terasawa F; Yamauchi K; Tozuka M; Okumura N
Blood; 2006 Sep; 108(6):1887-94. PubMed ID: 16705085
[TBL] [Abstract][Full Text] [Related]
16. Decreased lateral aggregation of a variant recombinant fibrinogen provides insight into the polymerization mechanism.
Mullin JL; Gorkun OV; Lord ST
Biochemistry; 2000 Aug; 39(32):9843-9. PubMed ID: 10933802
[TBL] [Abstract][Full Text] [Related]
17. Fibrinogen Matsumoto V: a variant with Aalpha19 Arg-->Gly (AGG-->GGG). Comparison between fibrin polymerization stimulated by thrombin or reptilase and fibrin monomer polymerization.
Tanaka H; Terasawa F; Ito T; Tokunaga S; Ishida F; Kitano K; Kiyosawa K; Okumura N
Thromb Haemost; 2001 Jan; 85(1):108-13. PubMed ID: 11204560
[TBL] [Abstract][Full Text] [Related]
18. Recombinant γT305A fibrinogen indicates severely impaired fibrin polymerization due to the aberrant function of hole 'A' and calcium binding sites.
Ikeda M; Kobayashi T; Arai S; Mukai S; Takezawa Y; Terasawa F; Okumura N
Thromb Res; 2014 Aug; 134(2):518-25. PubMed ID: 24968960
[TBL] [Abstract][Full Text] [Related]
19. Recombinant fibrinogen Vlissingen/Frankfurt IV. The deletion of residues 319 and 320 from the gamma chain of firbinogen alters calcium binding, fibrin polymerization, cross-linking, and platelet aggregation.
Hogan KA; Gorkun OV; Lounes KC; Coates AI; Weisel JW; Hantgan RR; Lord ST
J Biol Chem; 2000 Jun; 275(23):17778-85. PubMed ID: 10748039
[TBL] [Abstract][Full Text] [Related]
20. Thrombin-induced fibrinopeptide B release from normal and variant fibrinogens: influence of inhibitors of fibrin polymerization.
Ruf W; Bender A; Lane DA; Preissner KT; Selmayr E; Müller-Berghaus G
Biochim Biophys Acta; 1988 May; 965(2-3):169-75. PubMed ID: 3365451
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
